Filed with the SEC on · Summarized by InvestorsBot
Nancy A. Grygiel, Amgen’s SVP and Chief Compliance Officer, sold 2,970 shares in two open-market transactions on Aug. 6, 2026, at $402.16 per share. The sales totaled approximately $1,194,415, and she owned 7,340 shares afterward.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeAmgen SVP Rachna Khosla sells $1.35M in stock
Form 4 · Insider Trade · August 13, 2026
Amgen SVP Derek Miller sells about $1.57M in stock
Form 4 · Insider Trade · August 7, 2026
Amgen reports Q2 revenue growth and raises free cash flow to $3.5 billion
8-K · August 4, 2026
AMGEN filed an underwriting agreement dated Feb 17, 2026 — BofA Securities, Citigroup, J.P.
8-K · February 19, 2026
BREAKING: $AMGN sold $4.0B of senior notes across 2031/2036/2046/2056 maturities — net proceeds ≈ $3.961B.
8-K · February 19, 2026
AMGEN filed an 8-K (Item 9.01) on Feb 3, 2026 attaching a press release as Exhibit 99.1 (dated Feb 3, 2026).
8-K · February 3, 2026